Link Genomics, Inc.

Link Genomics, Inc. (Link) is a privately held pharmaceutical company. It is principally engaged in supplying various technologies and products to overcome cancer. The products of the company are based on its novel technology of genes and proteins analysis. The product pipeline of Link consists of three main projects to cure cancer, which include target for anti-cancer drugs, early diagnostic marker of cancer and marker for pathologic diagnosis of cancer. In addition, the company is also engaged in offering various services which include in vitro analysis and evaluation of molecules or drugs and re-profiling of drugs to pharmaceutical companies, academic and clinical institutes. The company has collaborations with numerous academic and clinical institutes. The company has its office located at Yamaguchi, Japan. Link is headquartered at Chuo-ku in Tokyo, Japan.

Street: 
Nihombashi IP Bldg. 4F
City: 
Tokyo
Postcode: 
1030024
Federal State : 
Japan
WebSite: 
www.linkgenomics.com
Fax: 
81-3-56521937

Company Index Score

Current Index Score Historical Index Score
  • Link Genomics, Inc. currently scores 50 % in the index.
  • Link Genomics, Inc. is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Link Genomics, Inc. is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets